| HOME >> MEDICINE >> TECHNOLOGY |
Table 115: CNS Disorder Therapeutic Market, Parkinson's Disease, Product Pipeline, 2011 175
Table 116: CNS Disorder Therapeutic Market, Schizophrenia, Product Pipeline, 2011 182
Table 117: CNS Disorder Therapeutic Market, Global, M&A Deals ($m), 2010-2011 206
Table 118: CNS Disorder Therapeutic Market, Global, Announced M&A Deals ($m), 2010-2011 207
Table 119: CNS Disorder Therapeutic Market, Global, Licensing Deals ($m), 2010-2011 212
Table 120: CNS Disorder Therapeutic Market, Co-developments, 2010-2011 218
1.2 List of Figures
Figure 1: CNS Disorder Therapeutic Market, Global, Revenue Share by Indication (%), 2010 16
Figure 2: CNS Disorder Therapeutic Market, Global, Revenue Forecast ($bn), 2002-2017 17
Figure 3: CNS Disorder Therapeutic Market, Global, Generic Share (%), 2010 and 2017 18
Figure 4: CNS Disorder Therapeutic Market, Global, Annual Cost of Treatment ($), 2002-2017 19
Figure 5: CNS Disorder Therapeutic Market, Revenue by Geography (%),2010 25
Figure 6: CNS Disorder Therapeutic Market, The US, Revenue Forecast ($m), 2002-2017 26
Figure 7: CNS Disorder Therapeutic Market, The US, Annual Cost of Treatment ($), 2002-2017 27
Figure 8: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Revenue Forecast ($m), 2002-2017 28
Figure 9: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2002-2017 30
Figure 10: CNS Disorder Therapeutic Market, Japan, Revenue Forecast ($m), 2002-2017 31
Figure 11: CNS Disorder Therapeutic Market, Japan, Annual Cost of Treatment ($), 2002-2017 32
Figure 12: CNS Disorder Therapeutic Market, Alzheimer's Disease Treatment Algorithm 34
Figure 13: CNS Disorder Therapeutic Market, Alzheimer's Disease, Global Revenue Forecast ($bn), 2002-2017 35
Figure 14: CNS Disorder Therapeutics Market, Alz
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |